Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Global Registry of Biorepositories
AddedFeb 17, 2024
UpdatedJun 18, 2026
Global Registry of Biorepositories

Global Registry of Biorepositories

NYC-based GRBio, a comprehensive online registry for biological collections in museums, herbaria, and biorepositories.

HQ
New York City, NY, US
Founded
2013
Overview
Compare
Fundraising
Employees

Global Registry of Biorepositories (GRBio) is a New York City-based medical organization dedicated to creating a comprehensive online registry for biological collections in natural history museums, herbaria, and other biorepositories. GRBio provides authoritative information and validated, standardized data, including addresses, contacts, and Darwin Core identifiers for institutions and collections.

GRBio has significantly impacted the field by consolidating data from various biorepositories into a single, accessible platform. This initiative has streamlined the process of accessing and sharing biological collection information, enhancing research and collaboration across institutions globally.

Global Registry of Biorepositories - Similar Companies

eBioinformatics logo

eBioinformatics

iSpecimen logo

iSpecimen

ispecimen.com

MolecularCloud logo

MolecularCloud

molecularcloud.org

BioAccel logo

BioAccel

Conversant Bio logo

Conversant Bio

NGX Bio logo

NGX Bio

The BioCollective logo

The BioCollective

Vivebio logo

Vivebio

Geneial logo

Geneial

geneial.com

Omix.ai logo

Omix.ai

AnaBios logo

AnaBios

anabios.com

Institute for Systems Biology logo

Institute for Systems Biology

isbscience.org

BiomedInnovations logo

BiomedInnovations

Intrepid Bioinformatics logo

Intrepid Bioinformatics

intrepidbio.com

Ibbr logo

Ibbr

Global Registry of Biorepositories - Quick Facts

Who are Global Registry of Biorepositories' competitors?

Companies similar to Global Registry of Biorepositories include eBioinformatics, iSpecimen, MolecularCloud and BioAccel.

When was Global Registry of Biorepositories founded?

Global Registry of Biorepositories was founded in 2013.

Where is Global Registry of Biorepositories' headquarters located?

Global Registry of Biorepositories' headquarters is located in New York City, NY, US.

When was Global Registry of Biorepositories' last funding round?

Global Registry of Biorepositories' most recent funding round was for $45M (USD) in June 2013.

How much has Global Registry of Biorepositories raised to-date?

As of Jun 27, 2013, Global Registry of Biorepositories has raised a total of $45M (USD).

How many employees does Global Registry of Biorepositories have?

Global Registry of Biorepositories has 5 employees as of Feb 4, 2024.

Global Registry of Biorepositories - Classification

Customer
  • Consumers
  • Education
  • Non-Profit
Main Product
  • Data
  • Information
Tags
  • Platform
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified